Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.06 USD | +1.99% | -6.58% | +192.92% |
06-14 | Novavax Files Emergency Use Authorization Amendment For Updated COVID-19 Vaccine | MT |
06-14 | FDA asks COVID vaccine makers to target KP.2 strain with updated shots | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+192.92% | 1.94B | |
+35.14% | 51.07B | |
-7.43% | 38.78B | |
+35.88% | 38.61B | |
-10.62% | 27.32B | |
+11.63% | 26.35B | |
-17.77% | 19.46B | |
+40.52% | 13.58B | |
+30.70% | 12.46B | |
-3.41% | 11.75B |
- Stock Market
- Equities
- NVAX Stock
- News Novavax, Inc.
- B. Riley Boosts Price Target on Novavax to $29 From $11, Maintains Buy Rating